Community hub
Recent from talks
Contribute something
Nothing was collected or created yet.
Ethylpropyltryptamine
View on Wikipedia
 | |
 | |
| Clinical data | |
|---|---|
| Other names | EPT; N-Ethyl-N-propyltryptamine |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug in the tryptamine family. It has been identified in illicit products in Japan.[1]
Use and effects
[edit]EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[2]
Interactions
[edit]Chemistry
[edit]Analogues
[edit]Analogues of EPT include methylethyltryptamine (MET), methylpropyltryptamine (MPT), diethyltryptamine (DET), dipropyltryptamine (DPT), among others.[2]
Society and culture
[edit]Legal status
[edit]United Kingdom
[edit]It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016.[3]
United States
[edit]EPT is unscheduled but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.
See also
[edit]References
[edit]- ^ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (January 2021). "Identification of six tryptamine derivatives as designer drugs in illegal products". Forensic Toxicology. 39 (1): 248–258. doi:10.1007/s11419-020-00556-5.
- ^ a b Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
- ^ "Misuse of Drugs Act 1971". Legislation.gov.uk.